AWCI
WST icon

Alpine Woods Capital Investors’s West Pharmaceutical WST Stock Holding History

Alpine Woods Capital Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$227K – 260
2020
Q2 		$227K Buy
+1,000
New +$196K 0.04% 233

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Alpine Woods Capital Investors's WST Position: Q3 2020 in Review

Alpine Woods Capital Investors sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 1,000 shares — an estimated $227K sold.

Alpine Woods Capital Investors first reported a position in WST in Q2 2020 and held it in 1 quarter. The position peaked at $227K in Q2 2020. 573 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • Alpine Woods Capital Investors reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 1,000 West Pharmaceutical shares in Q3 2020, an estimated $227K.
  • Alpine Woods Capital Investors first reported a position in West Pharmaceutical in Q2 2020 and held it in 1 quarter.
  • Alpine Woods Capital Investors's West Pharmaceutical position peaked at $227K in Q2 2020.
  • 573 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2020, filed 2 Nov 2020.